Did TRML beat earnings last quarter?

Tourmaline Bio (TRML) has beaten earnings estimates 9 of the last 11 quarters. See every beat, miss, and EPS surprise.

When is TRML's next earnings report?

See the upcoming earnings calendar for Tourmaline Bio (TRML) with EPS estimates and historical beat rate.

Do TRML insiders trade around earnings?

Track every Tourmaline Bio (TRML) insider transaction in the days before and after each earnings call — pattern of trades around the call is a key signal.

Tourmaline Bio (TRML) Earnings — Beats, Misses, Calendar

$47.98

Last traded 2025-10-30 — delisted

NASDAQ · Healthcare · Biotechnology · $1.2B mcap · 17M float · 5.51% daily turnover · Short 56% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Last Earnings 2025-11-06

EPS

$-0.78

▲ Beat +18.7%

Revenue

—

EPS Beat Streak: 7 quarters

Estimate vs Actual

Earnings Surprise History

9/14

EPS Beats

0/14

Revenue Beats

64%

EPS Beat Rate

Rev Beat Rate

Wall Street Forward Estimates

Quarterly

Annual

Earnings Call Transcripts

No transcripts available.

TRML Earnings

Estimate vs Actual

Earnings Surprise History

Wall Street Forward Estimates

Sign in to InsiderStreet